FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model

Cancer Chemotherapy and Pharmacology
Sarah R MuddMark Day

Abstract

Linifanib (ABT-869) is a multitargeted receptor tyrosine kinase inhibitor. This work aims to evaluate F-fluorodeoxyglucose-positron emission tomography (FDG-PET) as a pharmacodynamic (PD) biomarker for linifanib treatment utilizing the Calu-6 model of human non-small cell lung (NSCLC) cancer in SCID-beige mice. Animals received either vehicle or 12.5 mg/kg linifanib orally twice a day for the duration of the study. Imaging was performed at -1, 1, 3, and 7 days after beginning treatment (n = 12-14 per group). Linifanib inhibited tumor growth and suppressed tumor metabolic activity. Changes in tumor FDG uptake were observed as early as 1 day after beginning linifanib treatment and were sustained for the duration of the study. This study confirms that linifanib is efficacious in this xenograft model of human NSCLC and confirms FDG-PET is a potential PD biomarker strategy for linifanib therapy.

References

Sep 5, 2002·Nature Reviews. Cancer·Sanjiv Sam Gambhir
Feb 15, 2005·Drug Discovery Today·Homer H PienA Gregory Sorensen
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gary J KelloffDaniel C Sullivan
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathy D MillerGeorge W Sledge
Jan 19, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P SchöffskiH Van Poppel
Mar 15, 2006·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Anthony F Shields
May 2, 2006·Molecular Cancer Therapeutics·Daniel H AlbertSteven K Davidsen
Jan 4, 2007·The American Journal of Pathology·Balázs DömeJózsef Tímár
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John O PriorSerge Leyvraz
Aug 1, 2009·Journal of Hematology & Oncology·Jianbiao ZhouChien-Shing Chen
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chiung-Ing WongBoon-Cher Goh
Jun 18, 2010·CA: a Cancer Journal for Clinicians·Kristina M Cook, William D Figg
Jan 11, 2011·Gynecologic Oncology·Robert A Burger
Jan 15, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martin A WalterWolfgang A Weber
Feb 2, 2011·Nature Reviews. Drug Discovery·John Arrowsmith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.